KLK3 and posterior cortical atrophy: Although the introduction of PSA has greatly improved early PCa detection and stage migration as well as reduced PCa mortality [4], PSA has low specificity in discriminating between benign and malignant prostatic diseases, leading to unnecessary and/or repeat biopsies [21].